By vgreene, 5 May, 2015 F/U q2–6wk while gaining control, q1–6mo to monitor control, q3mo if step-down tx anticipated; consider asthma specialist consult [D]
By vgreene, 5 May, 2015 Written action plan [B] based on sx or peak flow; consider daily peak flow monitoring [B]
By vgreene, 5 May, 2015 Determine allergen exposure consider immuno tx SC as adjunct for persistent allergic asthma6
By vgreene, 5 May, 2015 Alternatives w prn SABA med dose ICS low dose ICS either LABA LAMA LTRA theophylline or zileuton3
